CALGARY, Alberta--(BUSINESS WIRE)--Fero Industries, Inc. (OTCBB: FROI) (the “Company”) is pleased to announce that Alan M. Schechter, Chairman and CEO of Pyro Pharmaceuticals, Inc. (“Pyro”) is slated to be appointed as the Company’s Chairman and CEO upon the closing of the proposed transaction contemplated by the Definitive Share Exchange Agreement between the two companies. Mr. Schechter is an entrepreneur with a 30 year track record in medical devices and biotechnology. He has raised over $40 million and participated in over $250 million in mergers and acquisitions. In addition, he has orchestrated acquisitions and joint ventures with large, publicly traded medical device and biotechnology companies. Mr. Schechter has been the CEO of six previous companies, four start-ups, and two turnarounds.
